March 1, 2008


IDSA E-mail Alerts: Ricin, Influenza, HIV/AIDS, Other ID Topics


IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Recent alerts have included:

CDC Alerts


FDA Alerts

IDSA frequently sends subscribers messages from the CDC regarding urgent public health issues, as well as ID-related messages from CDC and FDA on label changes, adverse events, newly approved drugs, and other safety information on FDA-approved drugs and biologics. 

To sign up for these services, IDSA members can visit http://www.idsociety.org/Content.aspx?id=4250.

< Previous Article | Next Article >

ACIP Makes New Recommendations on Flu, MMRV Vaccines
CID Supplement Provides New Insight on Clostridium difficile Infection
EIN Reports Cases of Hyperviscous Klebsiella pneumoniae with Liver Abscesses
IDSA E-mail Alerts: Ricin, Influenza, HIV/AIDS, Other ID Topics
Fluoroquinolone-resistant Meningococcus Reported
In the IDSA Journals
In Wake of Unusual Case, Immunization Experts Seek to Reassure Public about Vaccine Safety
Infection Prevention Brochure Updated
New Toolkit Helps Community Leaders Prepare for Pandemic Influenza
Hib Vaccination Increasing in Low-income Countries
Indonesia Sends WHO First H5N1 Samples in Months
President Announces Initiative to Fight Neglected Tropical Diseases
How to Code for Extra-long Subsequent Hospital Visits
IDSA Advocacy Update
NIAID Resistance Research Agenda, Shortcomings Highlighted in JID
Welcome, New IDSA Members!
Search Back Issues
Forward this Issue
Print-Friendly Version

Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA